NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2025 | $90,000 | Replaced |
| 2nd Quarter - Amendment | Aug 14, 2025 | $90,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Indian Health Service.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN DREW | — |
| TROY ZIMMERMAN | — |
Health Issues HCR
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN DREW | — |
| MIRIAM ELIZABETH GODWIN | — |
| MORGAN REID | — |
| JESSE ROACH | — |
| TROY ZIMMERMAN | — |
Medicare/Medicaid MMM
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN DREW | — |
| MIRIAM ELIZABETH GODWIN | — |
| MORGAN REID | — |
| JESSE ROACH | — |
| TROY ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.